GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
4Q Revenues up 8% year-over-year, Organic revenues* up 13% 4Q Net income of $554 million…
Year: 2023
Opthea To Present at Sequire Biotechnology Conference
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) — Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage…
VeryHealthyWater Introduces New Alkaline Drinking Water Distributor Sandy Utah
The people of Salt Lake County Utah now have easy access to an advanced ionized…
Soreide Law Group Announces FINRA Brokercheck Financial Fraud Tracking Tool
Securities Lawyers at the Soreide Law Group (1-888-760-6552) have announced a FINRA brokercheck tool to…
Small, Efficient 5G Multisector Antenna Indoor Base Station Achieves World’s First Demonstration using 28GHz
TOKYO, Jan 30, 2023 – (JCN Newswire) – Yokohama National University, NTT DOCOMO, INC., NIHON…
DOCOMO and YKK AP to Test Signal-permeable Windows Made with Aerogel for Easy Penetration by Radio Waves
TOKYO, Jan 30, 2023 – (JCN Newswire) – NTT DOCOMO, INC. announced today that in…
NEC announces plans for transition to a Company with a Nominating Committee, etc. and implementation of organizational reforms
TOKYO, Jan 30, 2023 – (JCN Newswire) – NEC Corporation (NEC; TSE: 6701) today announced…
NEC announces executive personnel changes
TOKYO, Jan 30, 2023 – (JCN Newswire) – NEC Corporation (“NEC”; TSE: 6701) today announced…
Mitek Adds Industry Veteran as Executive Chairperson to Capitalize on Growth Opportunities in Identity Verification
SAN DIEGO–(BUSINESS WIRE)–Mitek (NASDAQ: MITK, www.miteksystems.com), a global leader in digital identity and digital fraud…
Nuvias UK, an Infinigate Group Company, Partners with Pentera to Enhance its Cybersecurity Portfolio
Pentera’s security validation platform enables Nuvias’ customers to identify and mitigate their true cybersecurity risk…
Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar
Sandoz is seeking approval of high concentration formulation (HCF) adalimumab for use in all indications…
Press Release: Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for eosinophilic esophagitis
Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for…
Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Eosinophilic Esophagitis
Approximately 60% of patients aged 12 years and older treated with Dupixent 300 mg weekly…
KaJ Labs Confirms 200m LITHO Token Burn Schedule, Supports Listing Terra Luna Classic on Cryptocurrency Exchange Coinbase
Seattle, Washington–(Newsfile Corp. – January 30, 2023) – KaJ Labs has confirmed the upcoming 200M…
Toyota: Sales, Production, and Export Results for 2022 (January – December)
Toyota City, Japan, Jan 30, 2023 – (JCN Newswire) – Toyota Motor Corporation (TMC) announces…
Sorrento Issues “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted…
Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
PALO ALTO, Calif., Jan. 29, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced…
Two Hitachi Group Companies to Merge to Expand Robotic SI Business in Japan and ASEAN Countries
TOKYO, Jan 30, 2023 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501, “Hitachi”) today announced…
President Joko Widodo Launches Indonesia’s 2023 ASEAN Chairmanship
JAKARTA, Jan 30, 2023 – (ACN Newswire) – The Kick Off of Indonesia’s Chairmanship of…
Lecanemab Receives Priority Review Status in Japan
TOKYO and CAMBRIDGE, Mass., Jan. 29, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…